# A Study of the Effects of Paroxetine on the Pharmacokinetics of Paliperidone ER

> **NCT00791713** · PHASE1 · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 60 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Paliperidone ER

## Key facts

- **NCT ID:** NCT00791713
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** —
- **Final completion:** 2006-07
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2011-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00791713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00791713, "A Study of the Effects of Paroxetine on the Pharmacokinetics of Paliperidone ER". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00791713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*